Gujarat Terce Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
For the six months, sales was INR 227.47 million compared to INR 219.89 million a year ago. Revenue was INR 229.07 million compared to INR 221.58 million a year ago. Net loss was INR 9.73 million compared to INR 24.72 million a year ago. Basic loss per share from continuing operations was INR 1.31 compared to INR 3.33 a year ago. Diluted loss per share from continuing operations was INR 1.31 compared to INR 3.33 a year ago.